NMPA Approval

Olmesartan Medoxomil and Amlodipine Besylate Tablets

Approval Number

国药准字H20249787

Company山西鑫煜制药股份有限公司

Registration Date

December 25, 2024

Drug Information

Generic Name

奥美沙坦酯氨氯地平片

Dosage Form

片剂

Strength

本品每片含奥美沙坦酯20mg和苯磺酸氨氯地平5mg（以氨氯地平计）

Drug Type

化学药品

Registration Date

December 25, 2024

Company Information

Applicant Company

Company Name山西鑫煜制药股份有限公司

Company Address

山西省晋中市山西示范区晋中开发区汇通产业园园区1号路

Manufacturing Company

Company Name山西鑫煜制药股份有限公司

Company Address

山西省晋中市山西示范区晋中开发区汇通产业园园区1号路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.